Coeliac disease are not expected to be available to the general public for a while. Three main approaches have been proposed as new therapeutic modalities for coeliac disease: gluten detoxification, modulation of the intestinal permeability, and modulation of the immune response. Using genetically engineered wheat species, or wheat species that have been selectively bred to be minimally immunogenic, may allow the consumption of wheat. This, however, could interfere with the effects that gliadin has on the quality of dough. Alternatively, gluten exposure can be minimised by the ingestion of a combination of enzymes (prolyl endopeptidase and a barley glutamine-specific cysteine endopeptidase (EP-B2))
Corn gluten meal Corn gluten meal Corn gluten meal (CGM) is the principal protein of corn (maize) endosperm consisting mainly of zein and glutelin. It is a byproduct of corn processing that has historically been used as an animal feed. Despite the name, "corn gluten" does not contain true gluten, which is formed by the interaction of gliadin and glutenin proteins. In 1985, Dr. Nick Christians of Iowa State University discovered that CGM displayed pre-emergent herbicidal effects during a series of turf grass experiments. The use of corn gluten meal as an herbicide was patented in 1991, but, like many food-related substances used